Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1290922 | 0.93 | — | — | |
| SCHEMBL27613927 | 0.86 | CA12 (0.37) | — | |
| SCHEMBL189850 | 0.85 | ODC1 (0.33) | — | |
| Ammonia Solution, Strong SCHEMBL27877905 | 0.83 | ODC1 (0.32) | — | |
| SCHEMBL30483379 | 0.83 | ODC1 (0.32) | — | |
| SCHEMBL6277277 | 0.83 | — | — | |
| SCHEMBL483460 | 0.81 | HTR1B (0.31) | HTR1B | |
| SCHEMBL21061273 | 0.80 | DNM1 (0.34) | — | |
| SCHEMBL7698883 | 0.80 | ODC1 (0.32) | — | |
| SCHEMBL29915618 | 0.79 | CA12 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841105-B2 | Organic-inorganic composite material and process for producing same | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2412677-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | National University Corporation Okayama University (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | RIOX2, MAOA, FTO | HTR1B 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.